Royalty Pharma plc (RPRX) operating KPIs
RPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 8/3048% above fair value
$67.18+1.25 (+1.90%)
Close on Oct 30, 2026Market cap $38.63BP/E 38.2Yield –
KPIs
Operating metrics that drive Royalty Pharma's business
Coming soon
This tab will track the numbers specific to Royalty Pharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.